Top

World Journal of Surgery

Published in:

01-03-2015 | Original Scientific Report

Surgical Cure of Primary Hyperparathyroidism Ameliorates Gastroesophageal Reflux Symptoms

Authors: James Norman, Douglas Politz, Jose Lopez, Deva Boone, Alexander Stojadinovic

Published in: World Journal of Surgery | Issue 3/2015

Abstract

Objective

Gastroesophageal reflux disease (GERD) symptoms are commonly reported in primary hyperparathyroidism (pHPT). Although a calcium-mediated cause-and-effect relationship has been suggested, it remains unknown if parathyroidectomy improves GERD symptoms.

Methods

Over a 22-month period, 1,175 (39 %) of 3,000 consecutive adult patients with pHPT and symptomatic GERD (on prescription reflux medications daily for ≥2 years) undergoing parathyroidectomy were entered into a prospective study. Standardized Frequency Scale for Symptoms of GERD (FSSG) questionnaire was used to assess symptoms before, 1 and 2 years after parathyroidectomy.

Results

Daily prescription medication was used by 81 %, while 19 % used daily non-prescription drugs, both for a mean of 2.9 ± 0.7 years. GERD symptoms improved (26 %) or resolved completely (36 %) in 62 % of patients (p < 0.0001 vs. preoperative baseline) 1 year after parathyroidectomy. Prescription medications for GERD decreased from 81 % of enrolled patients to 26 % (p < 0.0001) 12 months postoperatively, with 39 % having complete symptom relief and taking no medications (p < 0.0001). Daily use of prescription GERD medications decreased to occasional over-the-counter drug use in 35 % after parathyroidectomy (p < 0.0001). Mean FSSG scores decreased significantly postoperatively (pre-op: 18.0 ± 8.0 vs. post-op: 10.0 ± 5.0; p < 0.0001), with significant improvements in all 12 FSSG categories, including motility (pre-op: 7.3 ± 3.0 vs. post-op: 4.4 ± 3.0; p < 0.0001) and acid reflux symptoms (pre-op: 10.8 ± 5.0 vs. post-op: 5.9 ± 4.0; p < 0.0001). Symptomatic improvements were durable 2 years after parathyroidectomy.

Conclusion

Symptomatic GERD is common in pHPT. Parathyroidectomy provides significant, durable relief of both motility and acid reflux symptoms allowing discontinuation of prescription drug use for GERD in most (74 %) patients providing yet another indication for parathyroidectomy in pHPT.

Weber T, Eberle J, Messelhäuser U, Schiffmann L, Nies C, Schabram J, Zielke A, Holzer K, Rottler E, Henne-Bruns D, Keller M, von Wietersheim J (2013) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 148(2):109–115CrossRefPubMed

Diniz ET, Bandeira F, Lins OG, Cavalcanti EN, de Arruda TM, Januário AM, Diniz KT, Marques TF, Azevedo H (2013) Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr Pract 19(2):219–225CrossRefPubMed

Reppe S, Stilgren L, Abrahamsen B, Olstad OK, Cero F, Brixen K, Nissen-Meyer LS, Gautvik KM (2007) Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab 292(5):E1465–E1473CrossRefPubMed

Joborn C, Joborn H, Rastad J, Akerström G, Ljunghall S (1988) Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 75(1):77–80CrossRefPubMed

Chan AK, Duh QY, Katz MH, Siperstein AE, Clark OH (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case–control study. Ann Surg 402(12):412–414

Gardner EC, Hersh T (1981) Primary hyperparathyroidism and the gastrointestinal tract. South Med J 74(2):197–199CrossRefPubMed

Abboud B, Daher R, Boujaoude J (2011) Digestive manifestations of parathyroid disorders. World J Gastroenterol 17(36):4063–4066CrossRefPubMedCentralPubMed

Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, Gangarosa LM, Thiny MT, Stizenberg K, Morgan DR, Ringel Y, Kim HP, Dibonaventura MD, Carroll CF, Allen JK, Cook SF, Sandler RS, Kappelman MD, Shaheen NJ (2012) Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143(5):1179–1187CrossRefPubMedCentralPubMed

Toghanian S, Johnson DA, Stålhammar NO, Zerbib F (2011) Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: a post hoc analysis of the 2007 national health and wellness survey. Clin Drug Investig 31(10):703–715CrossRefPubMed

10.

Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122(27):1500–1511

11.

Sawaya RA, Macgill A, Parkman HP, Friedenberg FK (2012) Use of the Montreal global definition as an assessment of quality of life in reflux disease. Dis Esophagus 25(6):477–483CrossRefPubMedCentralPubMed

12.

Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R (2007) Globale Konsensusgruppe. The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper]. Gastroenterology 45(11):1125–1140

13.

Holtmann G, Chassany O, Devault KR, Schmitt H, Gebauer U, Doerfler H, Malagelada JR (2009) International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 29(6):615–625CrossRefPubMed

14.

Chassany O, Holtmann G, Malagelada J, Gebauer U, Doerfler H, Devault K (2008) Systematic review: health-related quality of life (HRQOL) questionnaires in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 27(11):1053–1070CrossRefPubMed

15.

Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H, Ino K, Horikoshi T, Sugiyama T, Toki M, Ohwada T, Mori M (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39(9):888–891CrossRefPubMed

16.

Danjo A, Yamaguchi K, Fujimoto K, Saitoh T, Inamori M, Ando T, Shimatani T, Adachi K, Kinjo F, Kuribayashi S, Mitsufuji S, Fujiwara Y, Koyama S, Akiyama J, Takagi A, Manabe N, Miwa H, Shimoyama Y, Kusano M (2009) Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol 24(4):633–638CrossRefPubMed

17.

Norman J, Lopez J, Politz D (2012) Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg 214(3):260–269CrossRefPubMed

18.

Goodman A, Politz D, Lopez J, Norman J (2011) Intrathyroid parathyroid adenoma: incidence and location—the case against thyroid lobectomy. Otolaryngol Head Neck Surg 144(6):867–871CrossRefPubMed

19.

Reiher AE, Mazeh H, Schaefer S, Gould J, Chen H, Sippel RS (2012) Symptoms of gastroesophageal reflux disease improve after parathyroidectomy. Surgery 152(6):1232–1237CrossRefPubMed

20.

Edwards ME, Rotramel A, Beyer T, Gaffud MJ, Djuricin G, Loviscek K, Solorzano CC, Prinz RA (2006) Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 140(4):655–663 (discussion 653–654)CrossRefPubMed

21.

Pasieka JL, Parsons L, Jones J (2009) The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study. Surgery 146(6):1006–1013. doi:10.1016/j.surg.2009.10.021 CrossRefPubMed

22.

Melck AL, Armstrong MJ, Stang MT, Carty SE, Yip L (2010) Medication discontinuation after curative surgery for sporadic primary hyperparathyroidism. Surgery 148(6):1113–1118 (discussion 1118–1119)CrossRefPubMed

Title: Surgical Cure of Primary Hyperparathyroidism Ameliorates Gastroesophageal Reflux Symptoms
Authors: James Norman
Douglas Politz
Jose Lopez
Deva Boone
Alexander Stojadinovic
Publication date: 01-03-2015
Publisher: Springer US
Published in: World Journal of Surgery / Issue 3/2015
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-014-2876-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Surgical Cure of Primary Hyperparathyroidism Ameliorates Gastroesophageal Reflux Symptoms

Abstract

Objective

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2015

The Role of Preoperative Biliary Drainage in Severely Jaundiced Patients

Use of a 90° Drill and Screwdriver for Rib Fracture Stabilization

Patients Recovering From Abdominal Surgery Who Walked With Volunteers Exhibited Improved Postoperative Recovery Profiles During Hospitalization

Minimally Invasive Esophagectomy for Dysplastic Barrett’s Esophagus

Big Data as the Universal Language for Barrett’s Esophagus

The Selective Use of Laparoscopic Repair is Safe in High-Risk Patients Suffering from Perforated Peptic Ulcer